Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

164.84 0.76 −0.46%
Market cap
$9.8B
P/E
0.0×
Fwd P/E
−139×
Dividend yield
—
F-score
3/9
Altman Z
15.20
Beneish M
−2.96
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
95.84 119.01 140.49 173.98 404.37 414.05 352.70 295.43 318.92 278.76
Receivables
14.31 16.66 18.67 38.42 36.06 33.44 36.07 39.85 60.74 108.61
Inventory
6.84 11.22 13.28 42.58 15.81 23.01 37.84 41.99 57.68 63.56
Total current assets
120.02 149.46 176.57 262.88 469.44 486.13 443.86 395.46 449.79 474.98
Property, Plant, Equpment (Net)
7.59 11.79 19.15 22.06 24.01 68.97 94.40 103.21 97.87 113.25
Goodwill and Intangible Assets (Total)
6.57 3.15 — 448.74 423.83 398.92 374.00 349.09 329.58 208.63
Long Term Assets (Tax, Deferred)
— 0.24 0.21 — — — — — — —
Long-term assets (Other)
0.19 1.20 11.04 14.98 16.77 18.52 17.69 21.33 25.45 25.69
Total non-current assets
14.35 16.38 30.40 555.52 536.06 563.57 558.52 544.95 524.96 418.50
Total Assets
134.37 165.84 206.97 818.40 1,005.50 1,049.70 1,002.38 940.41 974.76 893.49
Accounts Payable
2.97 6.24 6.29 5.78 4.37 7.33 14.40 13.44 13.03 24.62
Accrued Expenses
13.91 20.45 23.96 51.92 45.33 56.03 57.96 60.57 62.10 76.65
Current Revenue (Deferred)
0.06 0.10 0.12 0.00 — — — — — —
Total current liabilities
16.94 26.79 30.37 57.70 49.70 63.36 72.36 74.01 75.13 101.28
Long Term Debt (Total)
— — — 58.44 250.11 352.73 353.57 353.31 69.46 68.11
Long Term Tax Liability (Deferred)
— 0.00 0.00 9.63 10.51 7.32 7.26 7.14 6.93 0.44
Non-current Liabilities (Other)
0.16 0.85 2.75 5.17 7.03 9.49 10.28 13.75 22.37 31.74
Total non-current liabilities
0.16 0.85 2.75 87.43 288.35 399.19 400.02 404.63 132.70 136.06
Total liabilities
17.10 27.63 33.11 145.13 338.05 462.55 472.38 478.65 207.83 237.33
Additional Paid In Capital
308.82 331.07 378.35 861.74 976.59 952.43 997.47 1,059.75 1,509.83 1,586.06
Common Stock (Net)
0.03 0.04 0.04 0.04 0.05 0.05 0.05 0.05 0.06 0.06
Retained Earnings
(192.09) (192.18) (205.13) (189.71) (310.06) (365.21) (464.41) (599.07) (745.44) (933.13)
Treasury Stock
0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13
Common Equity (Total)
117.27 138.20 173.86 673.27 667.45 587.15 530.00 461.77 766.93 656.16
Shareholders Equity (Total)
117.27 138.20 173.86 673.27 667.45 587.15 530.01 461.77 766.93 656.16
Shareholders Equity and Liabilities (Total)
134.37 165.84 206.97 818.40 1,005.50 1,049.70 1,002.38 940.41 974.76 893.49
Shares (Common)
33.94 34.62 36.11 43.50 45.25 46.97 47.75 49.12 56.44 57.51
Shareholders Equity (Tangible)
110.71 135.06 173.86 224.53 243.62 188.24 156.00 112.68 437.35 447.53
Net Debt
(95.84) (119.01) (140.49) (115.55) (154.26) (61.33) 0.88 57.88 (249.45) (210.65)
Total Debt
— — — 58.44 250.11 352.73 353.57 353.31 69.46 68.11

Fold the line items

In millions of $ except per-share values · columns are period end dates